A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

22 Sep 2021

New Index methodology: capacity to track progress prioritised for 2022

The Methodology Report for the next Access to Medicine Index is now online. It sets out the metrics the Access to Medicine Foundation will use in 2022...

13 Jul 2021

7 lessons from COVID-19 for pharma companies

There is a long way to go to curb the COVID-19 pandemic. To speed the end of the pandemic, and support a recovery that leaves no-one behind, the Acces...

22 Jun 2021

Foundation names Expert Review Committee for 2022 Access to Medicine Index

The Access to Medicine Foundation is pleased to announce the members of the Expert Review Committee for the next Access to Medicine Index, including f...

25 Mar 2021

Handful of new children’s meds on the horizon. But will they be accessible to children in LMICs?

New analysis: Just 7% of pharmaceutical companies’ R&D is for children under 12, despite significant gaps in paediatric treatment options.

26 Jan 2021

Now online: 2021 Access to Medicine Index

Pharma companies move to systematically make new medicines rapidly accessible to the poor. The 2021 Access to Medicine Index identifies eight pha...

08 Oct 2020

Early look: 5 key lines of investigation for the 2021 Index

Work on the next Access to Medicine Index is well underway. The Index research team is compiling analytical insights for the 20 company report cards,...

02 Oct 2020

Which information matters most? Transparency by Pharma that builds access to medicine plus trust and engagement

The world depends on the pharmaceutical industry for life-saving medicines and vaccines yet trust in the industry is low. Pharmaceutical companies hav...

16 Jul 2020

Tunnel vision or global outlook? Global pharma's dependency on the US

COVID-19 is a litmus test of whether health systems can pool assets and expertise and fairly distribute resources so that patients worldwide can benef...

10 Jul 2020

Will COVID-19 harm or help pharma's access to medicine efforts, asks 2021 Access to Medicine Index

The next Access to Medicine Index will be published in January 2021 – one year after China imposed the first lockdown to control COVID-19.  The...

09 Jun 2020

Progress against HIV, malaria and TB is under threat, putting children at risk. Here’s what is needed.

COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics. With the last mile in sight, great...

15 Apr 2020

Pharma’s path to 2030 captured in new framework for next Access to Medicine Index

The UN has called for a decade of action to achieve the Sustainable Development Goals and universal health coverage by 2030. Action by pharmaceutical...

14 Apr 2020

New products alone are not enough. Pharma can do more to halt COVID-19.

The COVID-19 epidemic will hit the most vulnerable people hardest. The pharmaceutical industry has a responsibility to do more than develop new vaccin...

20 Feb 2020

100+ investors endorse the Access to Medicine Index

Eight new investors have pledged support to the Foundation’s research and signed the Access to Medicine Index Investor Statement, taking the tota...

20 Jan 2020

Next Access to Medicine Index to tighten focus on top access priorities for pharma

In the coming weeks, the Access to Medicine Foundation will publish its latest framework of action for pharmaceutical companies on access to medicine....

29 Aug 2019

Foundation names Expert Review Committee for next Access to Medicine Index

The Foundation is pleased to announce the members of the Expert Review Committee for the next Access to Medicine Index, including six new members in 2...

22 Jul 2019

Pharma companies in Amsterdam for Foundation workshop on achieving access to medicine at scale

In its latest workshop, the Access to Medicine Foundation brought strategic leads from within pharmaceutical companies together with independent exper...

Back to top |